| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 02/26/2003 | CN1102073C Elecrochemical methods for recovery of ascorbic acid |
| 02/25/2003 | US6525099 N-substituted sulfonamide derivatives |
| 02/25/2003 | US6525072 Prevention and treatment of cellular disorders such as cancer |
| 02/25/2003 | US6525042 Sulfonyl derivatives |
| 02/25/2003 | US6525025 Controlling apoptosis; cardiovascular disorders; central nervous system disorders |
| 02/20/2003 | WO2003014106A1 METHOD FOR PREPARING OPTICALLY ACTIVE α-SUBSTITUTED HETEROCYCLICCARBOXYLIC ACID ESTER |
| 02/20/2003 | WO2003014100A1 Method for producing maleic anhydride |
| 02/20/2003 | WO2003014083A1 Spiro compounds |
| 02/20/2003 | WO2003014072A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 02/20/2003 | WO2003014064A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| 02/20/2003 | WO2003013510A1 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders |
| 02/20/2003 | WO2003013484A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 02/20/2003 | WO2002096516A8 Use of compositions comprising cyclooxygenase-2 selective inhibitors in combination with radiation for inhibition or prevention of cardiovascular disease |
| 02/20/2003 | WO2002079182A3 Transition-metal-catalyzed process for the preparation of sterically hindered n-substituted alkoxyamines |
| 02/20/2003 | WO2002030882A9 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses |
| 02/20/2003 | WO2002030860A9 Ketone compounds and compositions for cholesterol management and related uses |
| 02/20/2003 | WO2002024635A3 Aminoalcohol derivatives |
| 02/20/2003 | US20030036653 For prophylaxis and therapy of diseases associated with herpes viruses including human cytomegalovirus, herpes simplex viruses, Epstein-Barr virus, varicella-zoster virus, human herpesviruses- 6 and -7, and Kaposi herpesvirus |
| 02/20/2003 | US20030036532 Treatment of infections caused by parasites, especially malaria. |
| 02/20/2003 | US20030036475 Vanadium-phosphorus oxide catalysts with promoter reagents |
| 02/20/2003 | US20030035332 The preparation and use of ortho-sulfonamido arylhydroxamic acids as matrix metalloproteinase inhibitors |
| 02/20/2003 | DE20217957U1 Oxidative dyeing agent for keratin fibers uses 2-aminomethylene-substituted resorcinols as couplers, some of which are novel compounds |
| 02/20/2003 | CA2457814A1 Disulfide and thiosulfonate ligands and libraries comprising these ligands |
| 02/20/2003 | CA2456599A1 Spiro compounds |
| 02/20/2003 | CA2455754A1 Amine derivatives |
| 02/19/2003 | EP1284263A1 Derivatives of p- hydroxy phenyl propionic acid as antiproliferative agents |
| 02/19/2003 | EP1284257A2 Difluoromethylene aromatic ethers and their use as inhibitors of the glycine type-1 transporter |
| 02/19/2003 | EP1284140A2 Use of ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating aids |
| 02/19/2003 | EP1283825A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors |
| 02/19/2003 | EP1283723A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor |
| 02/19/2003 | EP1133491B1 Novel benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same |
| 02/19/2003 | EP0817786B1 Substituted tetronic acids useful for treating hiv and other retroviruses |
| 02/19/2003 | EP0799218B1 Diaryl-2-(5h)-furanones as cox-2 inhibitors |
| 02/19/2003 | EP0690867B1 Taxanes having furyl or thienyl substituted side-chain |
| 02/19/2003 | CN1398263A Method for prepn. of citaopram |
| 02/19/2003 | CN1398252A Dehydroamino acids compounds |
| 02/18/2003 | US6521765 Process for the preparation of 3-methyltetrahydrofuran |
| 02/18/2003 | US6521763 Method for producing gamma-butyrolactone |
| 02/18/2003 | US6521681 Phenol-free stabilization of polyolefin fibres |
| 02/18/2003 | US6521666 Inhibitors of α4 mediated cell adhesion |
| 02/18/2003 | US6521624 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 02/18/2003 | US6521607 (R)-chiral halogenated substituted N-phenoxy N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 02/16/2003 | CA2397698A1 Difluoromethylene aromatic ethers as inhibitors of glycine transport |
| 02/13/2003 | WO2003011851A2 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 02/13/2003 | WO2003011849A1 Process for the production of beraprost and its salts |
| 02/13/2003 | WO2003011847A1 Process for the preparation of 5-formylphthalide |
| 02/13/2003 | WO2003011846A2 Process for the preparation of 5-substituted isobenzofurans |
| 02/13/2003 | WO2003011822A2 Solid phase syntheis of salts of organic acid |
| 02/13/2003 | WO2003011819A1 Butyric acid derivatives |
| 02/13/2003 | WO2003011812A1 NOVEL AMINE DERIVATIVE HAVING HUMAN β-TRYPTASE INHIBITORY ACTIVITY AND DRUGS CONTAINING THE SAME |
| 02/13/2003 | WO2003011807A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 02/13/2003 | WO2003011449A1 Flow reactors for chemical conversions with hetergeneouos catalysts |
| 02/13/2003 | WO2003011279A1 (-)-olivil as antioxidant |
| 02/13/2003 | WO2003011278A1 Crystalline composition containing escitalopram |
| 02/13/2003 | WO2002059082A8 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| 02/13/2003 | WO2002040462A3 Cysteine protease inhibitors |
| 02/13/2003 | WO2001094329A8 Method for the production of 2- coumarone and substituted 2-coumarones |
| 02/13/2003 | US20030032841 Solid phase synthesis of salts of organic acid |
| 02/13/2003 | US20030032819 Dehydration of sugars derived from acidic hydrolysis of biomass to form furfural and hydroxymethylfurfural |
| 02/13/2003 | US20030032818 Reacting a sulfonic, phosphoric, or phosphonic acid with an aqueous strong organic or inorganic acid at 60-100 degrees c |
| 02/13/2003 | US20030032671 Propionic acid derivatives |
| 02/13/2003 | US20030032665 Method of inhibiting matrix metalloproteinases |
| 02/13/2003 | US20030032657 Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation |
| 02/13/2003 | US20030032644 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 02/13/2003 | US20030032633 Use of the active fraction (-)- Olivil as an antioxidant or free radical scavenger. |
| 02/13/2003 | US20030031736 Treating an aqueous suspension of Ginkgo biloba plant material or extract with an oxidizer, extracting the terpene trilactones and separating the organic layer containing the terpene trilactones from the aqueous layer; purification |
| 02/13/2003 | US20030031690 Cosmetic composition for preventing and treating acnes containing cryptotanshinone |
| 02/13/2003 | CA2456096A1 Novel amine derivative having human .beta.-tryptase inhibitory activity and medecine containing the same |
| 02/13/2003 | CA2456005A1 Process for the preparation of 5-formylphthalide |
| 02/13/2003 | CA2456004A1 Process for the preparation of 5-substituted isobenzofurans |
| 02/13/2003 | CA2455749A1 Butyric acid derivatives |
| 02/13/2003 | CA2453661A1 (-)-olivil as antioxidant |
| 02/13/2003 | CA2452665A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 02/13/2003 | CA2451090A1 Flow reactors for chemical conversions with heterogeneous catalysts |
| 02/13/2003 | CA2449804A1 Aromatic hydroxamic acid derivatives useful as hdac inhibitors |
| 02/12/2003 | EP1282614A1 Hydroxamic acid derivatives |
| 02/12/2003 | EP1282613A1 A pharmaceutical composition containing the extract of saururus chinensis baill useful as and anticancer agent and a process for the preparation thereof |
| 02/12/2003 | EP1282595A1 Novel phenyl-propargylether derivatives |
| 02/12/2003 | EP1282445A2 N-substituted dithiocarbamates for the treatment of biological disorders |
| 02/12/2003 | EP1282415A2 Compounds and methods for regulating bacterial growth and pathogenesis |
| 02/12/2003 | EP1032566B1 Method for the preparation of citalopram |
| 02/12/2003 | EP0988292B1 Piperazine derivatives and their use as anti-inflammatory agents |
| 02/12/2003 | CN1396918A Formulation for protection against oxidative stress containging benzofuranone derivatives |
| 02/12/2003 | CN1396903A Novel compound, their preparation and use |
| 02/12/2003 | CN1396819A Novel coupler for use in oxidative hair dyeing |
| 02/12/2003 | CN1396262A Preparation method of epoxyinalool or mixture containing epoxy inalool |
| 02/12/2003 | CN1396160A Process for preparing N-methyl piperethanamine salt |
| 02/12/2003 | CN1101153C Stablisation of flavours |
| 02/11/2003 | US6518440 Lignocellulose solids, containing cellulose, is added to a an aqueous acidic solution contained in a vessel, hydrolyzing the cellulose to form glucose, hydrolzying formed glucose to hydroxymethylfurfural, separating the product |
| 02/11/2003 | US6518433 Process for the preparation of nitroguanidine derivatives |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/11/2003 | US6518305 Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases |
| 02/11/2003 | US6518267 Protease inhibitors |
| 02/11/2003 | US6518066 Acylated Homoserine Lactone (AHL) compounds and AHL receptors derived from bacterial quorum sensing systems; inducible or repressible promotors regulate gene expression in plants and plant cells |
| 02/11/2003 | US6517994 Amplified photoresist |
| 02/11/2003 | US6517811 Compounds for cancer imaging and therapy |
| 02/06/2003 | WO2003010179A1 Process for the preparation of 2'-3'-dideoxy-2',3'-didehydro-nucleosides |
| 02/06/2003 | WO2003010162A1 Tetrahydropyridazine derivatives and their use as pesticides |
| 02/06/2003 | WO2003010153A1 N-alkyl-n-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses |
| 02/06/2003 | WO2003010143A1 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |